Convergent Therapeutics Receives $40 million Series A Extension Funding from Novo Holdings
| | | | |

Convergent Therapeutics Receives $40 million Series A Extension Funding from Novo Holdings

ByAlice Temper

Convergent Therapeutics Inc., a clinicalstage biotechnology company focusing on the development of radiopharmaceutical therapies for prostate cancer and other cancers, has secured a $40 million Series A extension funding from Novo Holdings. This additional funding will be used to advance the clinical development of Convergents radiopharmaceutical pipeline, specifically for their lead asset CONV01α. The funding…

Novostia Secures CHF 5.6 Million Funding for Heart Valve Prosthesis Development
| | | |

Novostia Secures CHF 5.6 Million Funding for Heart Valve Prosthesis Development

ByAlice Temper

Novostia, a medical technology company specializing in a disruptive heart valve prosthesis, has announced a leadership transition alongside the successful completion of a CHF 5.6 million funding round to accelerate the companys development efforts and advance its clinical evidence base. The newly appointed CEO, Soad El Ghazouani, brings over 25 years of experience in the…

Viromed Medical AG Plans Acquisition of ActivCell Group AG
| |

Viromed Medical AG Plans Acquisition of ActivCell Group AG

ByAlice Temper

Viromed Medical AG, a Germanybased company (Ticker: VMED; ISIN: DE000A3MQR65), has announced plans to acquire all shares in ActivCell Group AG, Switzerland, to strategically expand its product portfolio. The acquisition will allow Viromed to expand its treatment spectrum with additional indications and accelerate the market launch of its cold plasma product series in the European…

AdaptHealth Corp. Secures $950 Million Senior Secured Credit Facility
| | | |

AdaptHealth Corp. Secures $950 Million Senior Secured Credit Facility

ByAlice Temper

AdaptHealth Corp., a national leader in providing patientcentered, healthcareathome solutions including home medical equipment, medical supplies, and related services, announced the closing of a $950 million senior secured credit facility. The funding includes a $650 million Term Loan A and a $300 million revolving line of credit. The new Term Loan was used to fully…

RevBio Receives $2.4 Million NIH Grant for Clinical Trial of Bone Adhesive Biomaterial
| | |

RevBio Receives $2.4 Million NIH Grant for Clinical Trial of Bone Adhesive Biomaterial

ByAlice Temper

RevBio, Inc., a clinical stage medical device company, has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disease and Stroke (NINDS), part of the National Institutes of Health (NIH). The funding will support a 20patient pilot clinical trial to evaluate the safety and efficacy…

GT Medical Technologies Secures $35 Million Venture Loan Facility for Brain Tumor Treatment Expansion
| | |

GT Medical Technologies Secures $35 Million Venture Loan Facility for Brain Tumor Treatment Expansion

ByAlice Temper

GT Medical Technologies, Inc., a medical device company focused on improving the lives of patients with brain tumors, announced the securing of a $35 million venture loan facility. The funding will support strategic commercial and clinical expansion plans for GammaTile®, a targeted radiation solution embedded with Cesium131 seeds used to reduce tumor recurrence. The $35…

SpectraWAVE Secures $50M Series B Funding Round for Advancing Medical Imaging Technology
| |

SpectraWAVE Secures $50M Series B Funding Round for Advancing Medical Imaging Technology

ByAlice Temper

SpectraWAVE, a medical imaging company based in Bedford, Mass., specializing in improving treatment and outcomes for patients with coronary artery disease (CAD), has announced a $50M Series B funding round. The funding will be utilized to support the commercial expansion and add new products to their 510kcleared HyperVue™ Imaging System. The funding round was led…

Signet Healthcare Partners Announces Acquisition of Paragonix Technologies by Getinge
| |

Signet Healthcare Partners Announces Acquisition of Paragonix Technologies by Getinge

ByAlice Temper

Signet Healthcare Partners has announced the successful acquisition of Paragonix Technologies by Getinge, a global medical technology company. Paragonix Technologies is a leading innovator in organ transplantation and preservation technology, known for its groundbreaking devices and services for cardiothoracic and abdominal transplantation. The acquisition by Getinge marks a significant milestone in the growth and expansion…

Discure Technologies Secures $11 Million in Series A Funding for Breakthrough Device
| | |

Discure Technologies Secures $11 Million in Series A Funding for Breakthrough Device

ByAlice Temper

Discure Technologies Ltd. has successfully secured $11 million in an oversubscribed Series A financing round to advance the clinical testing of their groundbreaking device for degenerative disc disease. The companys Discure System, a bioelectronic implantable device, aims to revolutionize the treatment of degenerative disc disease (DDD) by addressing the underlying cause and regenerating the disc….

CSA Medical Inc. Completes $53 Million Series D Funding Round
| |

CSA Medical Inc. Completes $53 Million Series D Funding Round

ByAlice Temper

CSA Medical Inc., developer of The RejuvenAir® System, a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, has announced the completion of an oversubscribed $53 million Series D preferred stock equity financing. The funding round will support the company through expected U.S. Food and Drug Administration…